1. Home
  2. WETH vs HOWL Comparison

WETH vs HOWL Comparison

Compare WETH & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.09

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.39

Market Cap

17.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
HOWL
Founded
1992
2017
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
17.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
WETH
HOWL
Price
$1.09
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
134.8K
653.6K
Earning Date
04-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
18.40
EPS
0.32
N/A
Revenue
$45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.16
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.82
$0.27
52 Week High
$3.68
$2.23

Technical Indicators

Market Signals
Indicator
WETH
HOWL
Relative Strength Index (RSI) 43.99 47.88
Support Level $0.95 $0.35
Resistance Level $1.49 $0.43
Average True Range (ATR) 0.12 0.05
MACD -0.01 -0.00
Stochastic Oscillator 29.18 21.77

Price Performance

Historical Comparison
WETH
HOWL

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: